PLoS Biology (Jan 2012)

Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides.

  • Nuria Izquierdo-Useros,
  • Maier Lorizate,
  • Maria C Puertas,
  • Maria T Rodriguez-Plata,
  • Nadine Zangger,
  • Elina Erikson,
  • Maria Pino,
  • Itziar Erkizia,
  • Bärbel Glass,
  • Bonaventura Clotet,
  • Oliver T Keppler,
  • Amalio Telenti,
  • Hans-Georg Kräusslich,
  • Javier Martinez-Picado

DOI
https://doi.org/10.1371/journal.pbio.1001448
Journal volume & issue
Vol. 10, no. 12
p. e1001448

Abstract

Read online

Dendritic cells (DCs) are essential antigen-presenting cells for the induction of immunity against pathogens. However, HIV-1 spread is strongly enhanced in clusters of DCs and CD4(+) T cells. Uninfected DCs capture HIV-1 and mediate viral transfer to bystander CD4(+) T cells through a process termed trans-infection. Initial studies identified the C-type lectin DC-SIGN as the HIV-1 binding factor on DCs, which interacts with the viral envelope glycoproteins. Upon DC maturation, however, DC-SIGN is down-regulated, while HIV-1 capture and trans-infection is strongly enhanced via a glycoprotein-independent capture pathway that recognizes sialyllactose-containing membrane gangliosides. Here we show that the sialic acid-binding Ig-like lectin 1 (Siglec-1, CD169), which is highly expressed on mature DCs, specifically binds HIV-1 and vesicles carrying sialyllactose. Furthermore, Siglec-1 is essential for trans-infection by mature DCs. These findings identify Siglec-1 as a key factor for HIV-1 spread via infectious DC/T-cell synapses, highlighting a novel mechanism that mediates HIV-1 dissemination in activated tissues.